Home/Filings/4/0001179110-21-000862
4//SEC Filing

HAASER CHARLES B 4

Accession 0001179110-21-000862

CIK 0001121702other

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 10:29 AM ET

Size

5.3 KB

Accession

0001179110-21-000862

Insider Transaction Report

Form 4
Period: 2021-01-25
HAASER CHARLES B
Chief Accounting Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-01-25+11,50011,500 total
    Exercise: $16.49Exp: 2031-01-25Common Stock (11,500 underlying)
Footnotes (1)
  • [F1]These options will vest and become exercisable in equal quarterly installments over 4 years from 1/25/2021, beginning on 4/25/2021 and ending on 1/25/2025.

Issuer

YIELD10 BIOSCIENCE, INC.

CIK 0001121702

Entity typeother

Related Parties

1
  • filerCIK 0001230903

Filing Metadata

Form type
4
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 10:29 AM ET
Size
5.3 KB